Fundraising FoxLeonaBio
2 known investors
Find your way into LeonaBio
Sign up to see every warm intro you have to LeonaBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LeonaBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The company targets patients with diseases that have significant unmet medical needs.
Founders & leadership
ML
Mark LittonPresident and CEOMark Litton is president and CEO of LeonaBio, which develops therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. He has held leadership and strategy roles across biotechnology for over two decades and serves on the boards of Athira Pharma and Lumen Bioscience.
Investors · 2
Frequently asked questions
- What does LeonaBio do?
- LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The company targets patients with diseases that have significant unmet medical needs.
- Who are LeonaBio's investors?
- LeonaBio's investors include New Enterprise Associates (NEA), Propel Bio Partners.